PolyPid Current Valuation vs. Cash Flow From Operations
| PYPD Stock | USD 3.26 0.11 3.26% |
For PolyPid profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PolyPid to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PolyPid utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PolyPid's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PolyPid over time as well as its relative position and ranking within its peers.
Check out Your Equity Center. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PolyPid Cash Flow From Operations vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining PolyPid's current stock value. Our valuation model uses many indicators to compare PolyPid value to that of its competitors to determine the firm's financial worth. PolyPid is regarded third in current valuation category among its peers. It also is regarded third in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value PolyPid by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.PolyPid Current Valuation vs. Competition
PolyPid is regarded third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 3.49 Billion. PolyPid claims roughly 52.61 Million in current valuation contributing just under 2% to equities under Health Care industry.
PolyPid Cash Flow From Operations vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
PolyPid |
| = | 52.61 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
PolyPid |
| = | (21.96 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
PolyPid Cash Flow From Operations Comparison
PolyPid is currently under evaluation in cash flow from operations category among its peers.
PolyPid Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in PolyPid, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PolyPid will eventually generate negative long term returns. The profitability progress is the general direction of PolyPid's change in net profit over the period of time. It can combine multiple indicators of PolyPid, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform to address unmet medical needs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. Polypid operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people.
PolyPid Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on PolyPid. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PolyPid position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PolyPid's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in PolyPid without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Use Investing Themes to Complement your PolyPid position
In addition to having PolyPid in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
To fully project PolyPid's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PolyPid at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PolyPid's income statement, its balance sheet, and the statement of cash flows.